anidulafungin has been researched along with Sepsis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgarten, G; Bode, C; Boehm, O; Diedrich, B; Frede, S; Hoeft, A; Jahnert, S; Knuefermann, P; Meyer, R; Muenster, S; Steinhagen, F; Weisheit, C | 1 |
1 other study(ies) available for anidulafungin and Sepsis
| Article | Year |
|---|---|
Antifungal antibiotics modulate the pro-inflammatory cytokine production and phagocytic activity of human monocytes in an in vitro sepsis model.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Cells, Cultured; Cytokines; Echinocandins; Gene Expression; Humans; Immunosuppressive Agents; Inflammation; Itraconazole; Monocytes; Phagocytosis; Sepsis | 2015 |